Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes
Study objectives: The present study investigated the effect of dexmedetomidine infusion on bispectral index and hemodynamic values for patients undergoing cesarean section under general anesthesia as well as the postoperative maternal and fetal outcomes. Design and setting: This is randomized contro...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-10-01
|
Series: | Egyptian Journal of Anaesthesia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110184918301648 |
id |
doaj-a07dc9780dd94ee0a77bee72e59e8acd |
---|---|
record_format |
Article |
spelling |
doaj-a07dc9780dd94ee0a77bee72e59e8acd2020-11-25T02:30:48ZengTaylor & Francis GroupEgyptian Journal of Anaesthesia1110-18492018-10-01344145150Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomesEmad Eldeen A. Ibrahim0Mokhtar M. Amer1Mohamed E. Abuelnaga2Wafaa I. Abd-Elaal3Suez Canal University, Egypt; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Suez Canal University, EgyptSuez Canal University, Egypt; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Suez Canal University, EgyptSuez Canal University, Egypt; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Suez Canal University, Egypt; Corresponding author at: Suez Canal University, Ard Elgameiat, Ismailia City 41522, Egypt.Suez Canal University, Egypt; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Suez Canal University, EgyptStudy objectives: The present study investigated the effect of dexmedetomidine infusion on bispectral index and hemodynamic values for patients undergoing cesarean section under general anesthesia as well as the postoperative maternal and fetal outcomes. Design and setting: This is randomized controlled study done in operating rooms and postoperative recovery area. Patients: 44 Adult healthy pregnant females scheduled for elective Caesarian section delivery under general anesthesia were divided randomly in to two equal groups. Dexmedetomidine group and control group. Interventions: Unlike control group, Dexmedetomidine group: patients were given intravenous loading dose of DEX 1 mcg/kg before induction of anesthesia then intravenous infusion of DEX 0.4 mcg kg−1 hr−1 throughout surgery. Measurements: The BIS values; heart rate, blood pressure and MAC were monitored at 15 designated points of sequential events during anesthesia. The maternal sedation in the first postoperative hour was reported every 15 min. Apgar score of the neonates was assessed by the pediatrician 1 min and 5 min interval. All patients were asked about awareness or recall at the time of discharge and 6 h after. Results: BIS values, blood pressure, heart rate and MAC were significantly lower in DEX group at most different time intervals. Both groups of the study were matched as regard as Apgar score at 1 min. and 5 min. Alderete score was significantly lower in DEX group 15 min after extubation. However, both groups were matched 30 min after extubation. Sedation score was higher in Dex group at 5 and 15 min postoperatively. 10 patients in the control group needed extra dose of fentanyl. Conclusions: Dexmedetomidine is useful adjuvant during general anesthesia for CS as it attenuates hemodynamic responses to surgical stress, reduces needs for analgesic and anesthetic drugs together with favorable maternal and neonatal outcome. Keywords: Dexmedetomidine, Bispectral index, Caesarian sectionhttp://www.sciencedirect.com/science/article/pii/S1110184918301648 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Emad Eldeen A. Ibrahim Mokhtar M. Amer Mohamed E. Abuelnaga Wafaa I. Abd-Elaal |
spellingShingle |
Emad Eldeen A. Ibrahim Mokhtar M. Amer Mohamed E. Abuelnaga Wafaa I. Abd-Elaal Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes Egyptian Journal of Anaesthesia |
author_facet |
Emad Eldeen A. Ibrahim Mokhtar M. Amer Mohamed E. Abuelnaga Wafaa I. Abd-Elaal |
author_sort |
Emad Eldeen A. Ibrahim |
title |
Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes |
title_short |
Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes |
title_full |
Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes |
title_fullStr |
Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes |
title_full_unstemmed |
Dexmedetomidine infusion during caesarean section under general anaesthesia: Evaluation of maternal awareness using BIS, maternal and neonatal outcomes |
title_sort |
dexmedetomidine infusion during caesarean section under general anaesthesia: evaluation of maternal awareness using bis, maternal and neonatal outcomes |
publisher |
Taylor & Francis Group |
series |
Egyptian Journal of Anaesthesia |
issn |
1110-1849 |
publishDate |
2018-10-01 |
description |
Study objectives: The present study investigated the effect of dexmedetomidine infusion on bispectral index and hemodynamic values for patients undergoing cesarean section under general anesthesia as well as the postoperative maternal and fetal outcomes. Design and setting: This is randomized controlled study done in operating rooms and postoperative recovery area. Patients: 44 Adult healthy pregnant females scheduled for elective Caesarian section delivery under general anesthesia were divided randomly in to two equal groups. Dexmedetomidine group and control group. Interventions: Unlike control group, Dexmedetomidine group: patients were given intravenous loading dose of DEX 1 mcg/kg before induction of anesthesia then intravenous infusion of DEX 0.4 mcg kg−1 hr−1 throughout surgery. Measurements: The BIS values; heart rate, blood pressure and MAC were monitored at 15 designated points of sequential events during anesthesia. The maternal sedation in the first postoperative hour was reported every 15 min. Apgar score of the neonates was assessed by the pediatrician 1 min and 5 min interval. All patients were asked about awareness or recall at the time of discharge and 6 h after. Results: BIS values, blood pressure, heart rate and MAC were significantly lower in DEX group at most different time intervals. Both groups of the study were matched as regard as Apgar score at 1 min. and 5 min. Alderete score was significantly lower in DEX group 15 min after extubation. However, both groups were matched 30 min after extubation. Sedation score was higher in Dex group at 5 and 15 min postoperatively. 10 patients in the control group needed extra dose of fentanyl. Conclusions: Dexmedetomidine is useful adjuvant during general anesthesia for CS as it attenuates hemodynamic responses to surgical stress, reduces needs for analgesic and anesthetic drugs together with favorable maternal and neonatal outcome. Keywords: Dexmedetomidine, Bispectral index, Caesarian section |
url |
http://www.sciencedirect.com/science/article/pii/S1110184918301648 |
work_keys_str_mv |
AT emadeldeenaibrahim dexmedetomidineinfusionduringcaesareansectionundergeneralanaesthesiaevaluationofmaternalawarenessusingbismaternalandneonataloutcomes AT mokhtarmamer dexmedetomidineinfusionduringcaesareansectionundergeneralanaesthesiaevaluationofmaternalawarenessusingbismaternalandneonataloutcomes AT mohamedeabuelnaga dexmedetomidineinfusionduringcaesareansectionundergeneralanaesthesiaevaluationofmaternalawarenessusingbismaternalandneonataloutcomes AT wafaaiabdelaal dexmedetomidineinfusionduringcaesareansectionundergeneralanaesthesiaevaluationofmaternalawarenessusingbismaternalandneonataloutcomes |
_version_ |
1724827822345682944 |